Source:http://linkedlifedata.com/resource/pubmed/id/20724229
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
26
|
pubmed:dateCreated |
2010-9-6
|
pubmed:abstractText |
A novel, sensitive and reliable liquid chromatography-tandem mass spectrometric (LC-MS/MS) method was developed and validated for the determination of belinostat (PXD101) in human plasma. Oxamflatin was used as the internal standard. Liquid-liquid extraction of the plasma sample was performed using tert-butyl methyl ether as the organic solvent. Chromatographic separation was achieved on a BDS Hypersil C18 column (2.1 mm x1 00 mm, 5 microm) using gradient elution mode using 0.05% formic acid in water and 0.05% formic acid in acetonitrile as solvents A and B, respectively, 60/40. The run time was 6 min. The mass spectrometer was operated under a positive electrospray ionization condition and a multiple reaction monitoring mode. An excellent linear calibration was achieved in the range of 0.5-1000 ng/mL. An average recovery of belinostat for four quality controls was 72.6% and the recovery of the internal standard at 1000 ng/mL was 67.8%. The intra-day and inter-day precisions for belinostat were <or=8.0 and <or=10.3%, respectively, and their accuracy ranged from 100.2 to 106.7%. No significant matrix effect was identified. In analysis of patient samples, belinostat glucuronide was identified and baseline separated from belinostat. This well-validated assay has been applied for quantification of belinostat in plasma samples within 24h after the start of infusion for Asian hepatocellular carcinoma patients in a dose escalation study.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
1873-376X
|
pubmed:author | |
pubmed:copyrightInfo |
Copyright (c) 2010 Elsevier B.V. All rights reserved.
|
pubmed:issnType |
Electronic
|
pubmed:day |
15
|
pubmed:volume |
878
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2409-14
|
pubmed:meshHeading |
pubmed-meshheading:20724229-Antineoplastic Agents,
pubmed-meshheading:20724229-Chemical Fractionation,
pubmed-meshheading:20724229-Chromatography, Liquid,
pubmed-meshheading:20724229-Clinical Trials as Topic,
pubmed-meshheading:20724229-Humans,
pubmed-meshheading:20724229-Hydroxamic Acids,
pubmed-meshheading:20724229-Least-Squares Analysis,
pubmed-meshheading:20724229-Liver Neoplasms,
pubmed-meshheading:20724229-Reproducibility of Results,
pubmed-meshheading:20724229-Sensitivity and Specificity,
pubmed-meshheading:20724229-Tandem Mass Spectrometry
|
pubmed:year |
2010
|
pubmed:articleTitle |
A sensitive and specific liquid chromatography-tandem mass spectrometric method for determination of belinostat in plasma from liver cancer patients.
|
pubmed:affiliation |
Cancer Science Institute of Singapore, National University of Singapore, Singapore. csiwl@nus.edu.sg
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|